Literature DB >> 15536200

Cell division rates of primary human precursor B cells in culture reflect in vivo rates.

Jonathan Cooperman1, Robert Neely, David T Teachey, Stephen Grupp, John Kim Choi.   

Abstract

Bone marrow stroma-based cultures provide a powerful model for studying cell division and apoptosis of primary human precursor B cells. Studies using this model are elucidating the mechanisms by which stromal cells inhibit apoptosis of cultured normal precursor B cells and have demonstrated that the apoptotic rate of cultured leukemic precursor B cells can predict clinical outcome in acute lymphoblastic leukemia. In contrast to apoptosis, cell division in this model has not been well characterized. In this study, we quantified the rates of cell division in cultured primary human normal and leukemic precursor B cells by labeling precursor B cells with the fluorescent dye carboxyfluorescein diacetate, succinimyl ester. Based on the rate of decreasing fluorescent signal over 3 weeks, normal CD19(+), CD10(+) precursor B cells divided once every 90.5 hours, a number that correlates well with the known in vivo rate of 65.5 hours. The division rates were similar among different cultures and constant throughout the 3 weeks of culture, suggesting that the variable expansions of precursor B cells seen among different samples and culture durations are not secondary to different cell division rates. Unlike normal cells, cultured leukemic B cells had a heterogeneous division rate that ranged from once every 26-240 hours. These rates correlated well with their respective in vivo proliferation index. These findings indicate that the stroma-based cultures faithfully replicate in vivo cell division rates and can be used to elucidate the pathways that regulate cell division of primary human precursor B cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15536200     DOI: 10.1634/stemcells.22-6-1111

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  15 in total

1.  Immunosignature system for diagnosis of cancer.

Authors:  Phillip Stafford; Zbigniew Cichacz; Neal W Woodbury; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

Review 2.  High-dimensional single-cell cancer biology.

Authors:  Jonathan M Irish; Deon B Doxie
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

3.  A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression.

Authors:  Sabino Ciavarella; Anna Caselli; Antonella Valentina Tamma; Annalisa Savonarola; Giuseppe Loverro; Roberto Paganelli; Marco Tucci; Franco Silvestris
Journal:  Stem Cells Dev       Date:  2015-03-11       Impact factor: 3.272

4.  A study on the predictability of acute lymphoblastic leukaemia response to treatment using a hybrid oncosimulator.

Authors:  Eleftherios Ouzounoglou; Eleni Kolokotroni; Martin Stanulla; Georgios S Stamatakos
Journal:  Interface Focus       Date:  2017-12-15       Impact factor: 3.906

5.  The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL.

Authors:  David T Teachey; Dana A Obzut; Jonathan Cooperman; Junjie Fang; Martin Carroll; John K Choi; Peter J Houghton; Valerie I Brown; Stephan A Grupp
Journal:  Blood       Date:  2005-09-29       Impact factor: 22.113

Review 6.  Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.

Authors:  Stephan A Grupp; Christopher C Dvorak; Michael L Nieder; John E Levine; Donna A Wall; Bryan Langholz; Michael A Pulsipher
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

7.  Naive B Cell Output in HIV-Infected and HIV-Uninfected Children.

Authors:  Helen Payne; Gabriel Chain; Stuart Adams; Patricia Hunter; Natasha Luckhurst; Kimberly Gilmour; Joanna Lewis; Abdel Babiker; Mark Cotton; Avy Violari; Diana Gibb; Robin Callard; Nigel Klein
Journal:  AIDS Res Hum Retroviruses       Date:  2018-12-26       Impact factor: 2.205

8.  Microbubble array diffusion assay for the detection of cell secreted factors.

Authors:  Bryan Bobo; Dana Phelan; Jonathan Rebhahn; Michael S Piepenbrink; Bo Zheng; Tim R Mosmann; James J Kobie; Lisa A DeLouise
Journal:  Lab Chip       Date:  2014-07-31       Impact factor: 6.799

9.  Immunosignaturing can detect products from molecular markers in brain cancer.

Authors:  Alexa K Hughes; Zbigniew Cichacz; Adrienne Scheck; Stephen W Coons; Stephen Albert Johnston; Phillip Stafford
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  Physical characterization of the "immunosignaturing effect".

Authors:  Phillip Stafford; Rebecca Halperin; Joseph Bart Legutki; Dewey Mitchell Magee; John Galgiani; Stephen Albert Johnston
Journal:  Mol Cell Proteomics       Date:  2012-01-18       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.